Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
OTHER Tenascin other PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Carcinoma, Merkel Cell 2 D015266 ClinicalTrials
Leukemia, Myeloid, Acute 1 D015470 ClinicalTrials
Breast Neoplasms 1 D001943 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109583